Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries Release Date: Partner: AMFROM | Quality Improvement | Oncology | Benin, Congo, The Democratic Republic, Mali, Senegal, Togo | |
Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management Release Date: Partner: Beijing Guangda Precision Medicine Research Center | Quality Improvement | Inflammation & Immunology | China | |
Optimizing Antimicrobial Stewardship Program in Saudi Arabia Release Date: | Quality Improvement | Inflammation & Immunology | Saudi Arabia | |
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Release Date: | Research | Oncology | All | |
Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with Isavuconazole Release Date: | Research | Inflammation & Immunology | Australia, Germany, Israel, Italy, Spain, Switzerland | |
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer Release Date: | Education | Oncology | USA | |
Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026 Release Date: | Research | Vaccines | India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam | |
Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection Release Date: | Education | Vaccines | Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine | |
Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era Release Date: | Research | Vaccines | Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of | |
The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE Release Date: | Research | Hospital | China, Hong Kong | |
COVID-19 Disease Burden on the High Risk Population Release Date: | Education | Vaccines | All |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Multidisciplinary Team Education in Duchenne Muscular Dystrophy (see RFP for specific geographic scope) Release Date: | Education | Rare Disease | All | |
2023/2024 Global NASH ASPIRE Release Date: | Research | Internal Medicine | All | |
Improving Metastatic Breast Cancer (mBC) Quality of Care and Equity via Meaningful Capacity Building in South East Asia Release Date: Partner: Conquer Cancer®, the ASCO Foundation | Quality Improvement | Oncology | Hong Kong, Indonesia, Malaysia, Myanmar, Papua New Guinea, Philippines, Singapore, Solomon Islands, Taiwan, Thailand, Vietnam | |
Alopecia Areata Education for Pediatric Dermatologists, Dermatologists, and Advanced Practice Providers Release Date: | Education | Inflammation & Immunology | USA | |
Implementation of Revised USP <797> Pharmaceutical Compounding-Sterile Preparations: Challenges and Opportunities Release Date: | Education | Hospital | USA | |
Improving Care for Patients with Multiple Myeloma Release Date: | Education | Oncology | USA | |
HRRm Testing in Metastatic Prostate Cancer Release Date: | Education | Oncology | All | |
Advancing Oncology Education for Healthcare Professionals Release Date: | Education | Oncology | Benin, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Djibouti, Gabon, Guinea, Madagascar, Mali, Niger, Rwanda, Senegal, Seychelles, Togo | |
Providing Appropriate Medical Care for IBD Patients Release Date: Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD) | Quality Improvement | Inflammation & Immunology | Japan | |
Real World Evidence of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis Release Date: | Research | Inflammation & Immunology | All | |
Addressing Gaps in Care for Patients with Multiple Myeloma (Europe) Release Date: | Education | Oncology | All | |
Improving Breast Cancer (BC) Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa Release Date: Partner: Conquer Cancer®, the ASCO Foundation Review Process: Expert Review Panel | Quality Improvement | Oncology | Congo, The Democratic Republic, Ethiopia, Ghana, Malawi, Mali, Mozambique, Rwanda, Senegal, Tanzania, United Republic of, Uganda, Zambia, Zimbabwe |